Tigatuzumab

Tax included
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
MedChemExpress 
HY-P99270

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
Cancer-programmed cell death
CAS
918127-53-4